Navigation Links
Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
Date:9/22/2008

of the disease.

About Enobia Pharma Inc.

Enobia Pharma Inc., is a private, Montreal based company focused on the development of therapeutics to treat serious bone disorders for which there is no currently approved drug therapy. Enzyme Replacement Therapy for the treatment of hypophosphatasia is the Company's lead program. In 2007 Enobia completed a $40M Series B financing lead by OrbiMed Advisors and CTI Life Sciences.

Company Contact: Julie Anne Smith, (514) 596-2901, extension 214


'/>"/>
SOURCE Enobia Pharma
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
2. Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
3. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
4. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
5. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
6. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
7. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
8. VIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008
9. Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer
10. Vanda Pharmaceuticals Provides Update on Iloperidone
11. Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 GlaxoSmithKline plc [GSK] (NYSE: ... announced an exclusive licensing agreement in the United ... of NB-001, a novel, patented compound representing the ... Developed by NanoBio, NB-001 provides significant antimicrobial activity ... herpes labialis . ,, Cold sores are ...
(Date:12/16/2009)... LAKE CITY, Dec. 16 TechniScan, ... the "Company"), a medical device company engaged in ... ultrasound imaging system, announced today that Joe Pepper, ... of Directors. ,, Board Chairman Ken Hungerford ... large medical devices companies, including GE OEC Medical ...
(Date:12/16/2009)... an inhalation drug delivery company, today announced that it ... financing round, exceeding the targeted total raise amount of ... Series A round will be utilized to continue the ... have the runway and resources to effectively demonstrate the ... Neville, CEO of Savara. ,, The company also ...
Breaking Medicine Technology:GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 2In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 2In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 3Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent 2Schering Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck 52646 1Schering Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck 52646 2U S Senator Sherrod Brown to Lend Support at MedWorks Free Medical Clinic This Weekend 52644 1U S Senator Sherrod Brown to Lend Support at MedWorks Free Medical Clinic This Weekend 52644 2Spirituality and Medicine 3A Can the Two Walk Together 3F 52642 1Spirituality and Medicine 3A Can the Two Walk Together 3F 52642 2
... S. Singer, M.D., Ph.D. Contributing Editor Harvard Medical School ... failure in African American patients has underscored the concept ... medication. This concept holds true for a wide ... due to individual genetic variations. As the field of ...
... M.D. Contributing Editor The first human case of West Nile ... Kansas in late June. The CDC has released few ... first documented incidence of the mosquito borne disease in the ... kb. It primarily infects birds and mosquitoes, with humans, ...
Other Medicine Technology:Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 2Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 2West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 4
(Date:12/16/2009)... factor for use, expert says, , , WEDNESDAY, Dec. 16 ... much less likely to die when they receive an ... study included 4,685 people, ages 65 to 85, who ... ventricular fraction (a measure of the heart,s pumping ability) ... period, those who were treated with standard medication and ...
(Date:12/16/2009)... OrthoAccel Technologies, Inc., developers of the ... device to enhance orthodontics, announced Alison Davies as ... Ms. Davies has spent the last fourteen ... industry, most recently for nine years as a ... of Invisalign . ,, (Logo: ...
(Date:12/16/2009)... -- MassMutual,s Retirement Services Division has announced plans ... in Q2 2010. The new platform will include ... change materials in a variety of themes. Plan ... a menu of creative options to support the ... The new RetireSmart participant engagement platform will be ...
(Date:12/16/2009)... at the heart of diagnostic procedures in cardiology. The ... which accumulates the expertise of European cardiovascular imagers, is ... that it is written with a patient rather than ... the patient, with the aid of imaging. , ... themes involving theory and practice of cardiac imaging and ...
(Date:12/16/2009)... Fortune 1000 employers strongly indicates that wellness programs have a ... , ... Minneapolis, MN (PRWEB) December 16, ... that 78 percent of employers have improved employee participation in ... In the survey, conducted by Hallmark Insights, a leader ...
Breaking Medicine News(10 mins):Health News:Implanted Defibrillator Might Extend Life 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 2Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 3Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 4Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 5Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 2Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 3Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2
... Illinois researchers describes how an impaired anti-inflammatory response plays ... . ,Published in the Journal of Immunology, ... signals that bind to specific receptors on cells and ... cell. ,Interleukins, interferons, tumour necrosis factors, and ...
... pressure, high cholesterol, and inactivity are a growing problem in ... , The study was conducted by a team of ... Morrell, at the University of New Hampshire. ,As ... 800 undergraduates enrolled in a general-education nutrition course who completed ...
... have found that obesity worsens the quality of life ... levels including pain, fatigue, physical function and overall ... team of researchers led by Dr Siri Lillegraven at ... study, researchers examined 1041 obese patients and normal weight ...
... epidemiologists has provided new information on the prevalence of ... and the association of the bacteria with oral bone ... four bacteria known to cause periodontal disease were more ... those without these oral pathogens. ,Two widely ...
... of a 227 patient Phase 2 trial presented at EULAR ... 180 mg (with background methotrexate) reduces the progression of bone ... antibody which binds to and inhibits the RANK Ligand. The ... and survival and thereby plays a key role in rheumatoid ...
... surveillance system needs to be fixed, argues an editorial in ... recent analysis of the diabetes drug rosiglitazone (Avandia) which raised ... approved by the US Food and Drug Administration (FDA) in ... Its popularity has increased steadily, with more than one million ...
Other Medicine News:Health News:Cytokine Resistance Contributes to Pathology of Type 2 Diabetes 2Health News:Post Menopausal Women are Prone to Gum Disease 2Health News:Denosumab Reduces Bone Erosion 2Health News:Drug Surveillance System Needs to Be Fixed 2
Claes Shielded Retinotomy Scissors, Curved Vertical...
Claes Shielded Retinotomy Scissors, Vertical...
Indirect hemagglutination assay (IHA) for the detection and semi-quantitation of human antibodies to the bacteria of the genus Leptospira. Each kit contains test cells, control cells, and positive an...
... antibody (IFA) test for ... of human serum IgG ... capsid antigen (VCA). Each ... slides, FITC IgG conjugate, ...
Medicine Products: